65 related articles for article (PubMed ID: 9421193)
1. Effect of phospholipids on adsorption and penetration of human T-cell leukemia virus type I.
Yang D; Iwai H; Yamamoto A; Fu D; Hoshino H
Biochim Biophys Acta; 1997 Nov; 1349(1):25-32. PubMed ID: 9421193
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adsorption of human T-cell-leukemia virus type 1 by a plant lectin, wheat-germ agglutinin.
Yang D; Haraguchi Y; Iwai H; Handa A; Shimizu N; Hoshino H
Int J Cancer; 1994 Jan; 56(1):100-5. PubMed ID: 8262663
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
Haraguchi Y; Takeuchi Y; Hoshino H
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
[TBL] [Abstract][Full Text] [Related]
4. Identification of membrane antigens important for adsorption of human T-cell leukaemia virus type I.
Fu DX; Haraguchi Y; Jinno A; Yang D; Hoshino H
Res Virol; 1998; 149(6):383-92. PubMed ID: 9923014
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y
J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell leukemia virus type I: pseudotype neutralization of Japanese and American isolates with human and rabbit sera.
Hoshino H; Clapham PR; Weiss RA; Miyoshi I; Yoshida M; Miwa M
Int J Cancer; 1985 Dec; 36(6):671-5. PubMed ID: 2415468
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806
[TBL] [Abstract][Full Text] [Related]
8. Human T cell leukemia viruses use a receptor determined by human chromosome 17.
Sommerfelt MA; Williams BP; Clapham PR; Solomon E; Goodfellow PN; Weiss RA
Science; 1988 Dec; 242(4885):1557-9. PubMed ID: 3201246
[TBL] [Abstract][Full Text] [Related]
9. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D; Ramos JC; Barber GN
J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication.
Tanaka M; Sun B; Tezuka K; Fujisawa J; Tanaka Y; Hoshino H; Miwa M
Microbes Infect; 2010 Feb; 12(2):119-25. PubMed ID: 19892032
[TBL] [Abstract][Full Text] [Related]
11. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
12. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
13. Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I.
Hoshino H; Weiss RA; Clapham P; Miwa M; Miyoshi I; Yoshida M; Sugimura T
Princess Takamatsu Symp; 1984; 15():159-64. PubMed ID: 6152758
[TBL] [Abstract][Full Text] [Related]
14. Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.
Clapham P; Nagy K; Weiss RA
Proc Natl Acad Sci U S A; 1984 May; 81(9):2886-9. PubMed ID: 6326149
[TBL] [Abstract][Full Text] [Related]
15. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.
Silverman LR; Phipps AJ; Montgomery A; Ratner L; Lairmore MD
J Virol; 2004 Apr; 78(8):3837-45. PubMed ID: 15047799
[TBL] [Abstract][Full Text] [Related]
18. Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.
Panfil AR; Dissinger NJ; Howard CM; Murphy BM; Landes K; Fernandez SA; Green PL
J Virol; 2016 Jan; 90(7):3760-72. PubMed ID: 26819304
[TBL] [Abstract][Full Text] [Related]
19. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
Balestrieri E; Sciortino MT; Mastino A; Macchi B
Antiviral Res; 2005 Dec; 68(3):154-62. PubMed ID: 16271772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
